Related Experiment Video
Updated: Jun 3, 2026

Optical Control of a Neuronal Protein Using a Genetically Encoded Unnatural Amino Acid in Neurons
Published on: March 28, 2016
Effect of CIPC and intervention of Ca(2+)-regulated factors on CaN, cbl-b and p-AKT expression in neurons
Yong-Mei Jiang1, Hui Zhang, Lin Yin
1Department of Neurology, Second Affiliated Hospital, Dalian Medical University, Dalian 116027, China.
Abstract:
CaN induces the apoptosis in neurons, but the influence of CIPC and the intervention of pretreament with Ca(2+)-regulated factors, such as nimodipine, MK801 and cyclosporine A, on CaN expression is not clear. We also do not know whether cbl-b takes part in the induction of ischemia or induces an expression change of cbl-b in CIPC. So we will discuss the effect of CIPC, pretreatment with nimodipine, MK801 and cyclosporine A on the expression of the CaN, cbl-b and p-AKT in the hippocampus neurons. In our study, we established rat models including sham, ischemia, CIPC, nimodipine, MK801 and cyclosporine A. The neurological deficit scores were processed. The right hippocampus was removed and stained with TTC, and the volume of cerebral infarction was calculated. The apoptotic neurons were detected by TUNEL staining. The expressions of CaN, cbl-b and p-AKT at the protein level were examined by Western blotting, and the transcription of cbl-b by RT-PCR, respectively. The results showed that the neurological deficit scores, the volume of the cerebral infarction, the numbers of the apoptotic neurons, the protein expression of CaN, cbl-b and the transcription of cbl-b were the highest in the ischemia and MK801 groups, there were no difference between the two groups(P>0.05); these factors in CIPC group were all lower than those in the ischemia group(P<0.05); and much lower in the nimodipine and cyclosporine A group than those in the CIPC group (among them, the volume of the cerebral infarction in the nimodipine and cyclosporine A groups P<0.01, the expression of CaN in nimodipine group P<0.01, others were P<0.05), but no significant difference existed between the nimodipine and cyclosporine A groups(P>0.05). The expression of p-AKT was the lowest in the ischemia and MK801 groups, and there was no difference between the two groups (P>0.05), This factor was higher in CIPC group than that in the ischemia group (P<0.05); it was the highest in the nimodipine and cyclosporine A groups among these groups (the nimodipine group P<0.01, the cyclosporine A group P<0.05), no significant difference existed between the nimodipine and cyclosporine A groups (P>0.05. Continuous ischemia increases the expression of CaN, and the transcription and the protein expression of cbl-b. Cbl-b reduces the phosphorylated expression of AKT, ultimately activating apoptosis. CIPC inhibits above process and reduces the expression of CaN and cbl-b, and increases the expression of p-AKT, thereby inhibiting apoptosis in neurons. Nimodipine and cyclosporine A can reduce the expression of CaN and cbl-b, and increase the expression of p-AKT, via a moderate increase in the concentration of intracellular calcium and inhibition of the activity of CaN; MK801 counteracts the effect of CIPC.
Insights
Cerebral ischemia increases calpain (CaN) and cbl-b expression, promoting neuronal apoptosis. CIPC treatment, nimodipine, and cyclosporine A inhibit this by reducing CaN and cbl-b, while MK801 exacerbates ischemia effects.
Area of Science:
- Neuroscience
- Molecular Biology
- Pathology
Background:
- Calpain (CaN) induces neuronal apoptosis, but its regulation during cerebral ischemia and the role of cbl-b are unclear.
- The influence of CIPC and Ca(2+)-regulated factors like nimodipine, MK801, and cyclosporine A on CaN expression needs investigation.
- Understanding the involvement of cbl-b in ischemia and CIPC-induced expression changes is crucial.
Purpose of the Study:
- To investigate the effects of CIPC, nimodipine, MK801, and cyclosporine A on CaN, cbl-b, and p-AKT expression in rat hippocampus neurons.
- To elucidate the molecular mechanisms underlying neuronal apoptosis regulation in cerebral ischemia and CIPC.
- To determine the role of cbl-b in ischemia-induced apoptosis and its modulation by therapeutic interventions.
Main Methods:
- Establishment of rat models for sham, ischemia, CIPC, nimodipine, MK801, and cyclosporine A.
- Assessment of neurological deficit scores, cerebral infarction volume (TTC staining), and apoptotic neurons (TUNEL staining).
- Examination of CaN, cbl-b protein expression (Western blotting) and cbl-b transcription (RT-PCR), and p-AKT expression.
Main Results:
- Ischemia and MK801 significantly increased neurological deficits, infarction volume, apoptotic neurons, and CaN/cbl-b expression, while decreasing p-AKT.
- CIPC treatment reduced these ischemia-induced markers and increased p-AKT.
- Nimodipine and cyclosporine A further reduced CaN/cbl-b and increased p-AKT, suggesting neuroprotective effects by modulating intracellular calcium and CaN activity.
Conclusions:
- Continuous ischemia elevates CaN and cbl-b, leading to AKT dephosphorylation and apoptosis.
- CIPC inhibits this pathway, reducing CaN/cbl-b and increasing p-AKT, thereby protecting neurons.
- Nimodipine and cyclosporine A offer neuroprotection by decreasing CaN/cbl-b and increasing p-AKT, while MK801 counteracts CIPC's beneficial effects.
Related Concept Videos
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
cAMP-dependent Protein Kinase Pathways
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
Inhibition of Cdk Activity
Intracellular Signaling Cascades